This eBook, From Prescribing to Pick Up: Navigating the Access & Affordability Landscape, provides a focused view into CoverMyMeds’ access and affordability solutions and how they help biopharma brands overcome patient barriers. It highlights their integrated network, innovative technology, and human support services — including prior authorization solutions, hub services, and copay assistance — designed to streamline the patient journey, improve speed to therapy, and enhance health outcomes.
FDA reportedly shelves its Commissioner’s National Priority Voucher program, Eli Lilly breaks ground on a $3.5 billion Pennsylvania manufacturing site for next-generation obesity treatments, and Parexel’s Stacy Hurt on how small protocol decisions can become enrollment and retention barriers.
Every protocol decision affects patients, and only those with lived disease experience can identify true burden — from invasive biopsies to daily trial demands.
Moderna lays out an oncology-driven growth plan at its 2026 Analyst Day, Pfizer and Blackstone sign a co-funding deal worth up to $1.5 billion for berobenatide, and Parexel’s Stacy Hurt on how patients’ use of AI is reshaping sponsor communication.
Pfizer and Blackstone Life Sciences sign a co-funding deal in which Blackstone is set to provide up to $1.5 billion through 2028 to advance berobenatide.
